Table 3.
Characteristics Associated With Fluoroquinolone Prescribing for Uncomplicated UTI in Women Aged ≥18 Years Involving Antibiotic Prescription, NAMCS/NHAMCS 2002–2011 (N = 5686)
| Characteristic | Percentage of Visits That Involved Fluoroquinolone Prescription | P Value* | AOR (95% CI) for Fluoroquinolone Prescribing |
|---|---|---|---|
| Age group (years) | <.001 | ||
| 18–29 | 39% | 1.00 | |
| 30–49 | 51% | 1.67 (1.26–2.21) | |
| 50–69 | 52% | 1.75 (1.28–2.37) | |
| ≥70 | 58% | 2.47 (1.62–3.77) | |
| Race | .57 | ||
| White | 49% | 1.00 | |
| Black | 48% | 0.99 (.69–1.41) | |
| Other | 41% | 0.73 (.39–1.38) | |
| Insurance | .28 | ||
| Private | 50% | 1.00 | |
| Medicare/Medicaid | 49% | 0.83 (.63–1.10) | |
| Other | 43% | 0.83 (.58–1.21) | |
| Visit setting | .27 | ||
| Physician's office | 50% | 1.00 | |
| Hospital outpatient department | 45% | 0.91 (.68–1.22) | |
| Emergency department | 47% | 1.07 (.84–1.36) | |
| Provider specialtya | .01 | ||
| Family/general practice | 48% | 1.00 | |
| Internal medicine | 62% | 1.95 (1.14–3.31) | |
| Urology | 42% | 0.72 (.42–1.24) | |
| Other | 39% | 0.70 (.39–1.27) | |
| US Census region | .24 | ||
| Northeast | 54% | 1.00 | |
| Midwest | 47% | 0.73 (.45–1.18) | |
| South | 50% | 0.81 (.52–1.27) | |
| West | 43% | 0.61 (.38–1.00) |
The number in bold fonts indicate P < .05.
Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; NAMCS, National Ambulatory Medical Care Survey; NHAMCS, National Hospital Ambulatory Medical Care Survey; UTI, urinary tract infection.
a Data available for NAMCS only. Accordingly, odds ratios are from a separate model that includes only data from NAMCS.
* χ2 test.